Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis
- 1 February 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (2), 394-397
- https://doi.org/10.1128/aac.35.2.394
Abstract
By using an assay system based on a human hepatoblastoma cell line (HB611) that continuously synthesizes hepatitis B virus DNA, the following compounds were found to inhibit hepatitis B virus DNA synthesis at concentrations that were significantly lower than their minimum cytotoxic concentrations: 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP), (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine, 9-(phosphonylmethoxyethyl)adenine, 2',3'-dideoxy-2',3'-didehydrocytidine, and 2',3'-dideoxycytidine. The most potent compound was PMEDAP (50% effective concentration, 0.02 micrograms/ml). The selective index, or ratio of the 50% cytotoxic concentration to 50% effective concentration, of PMEDAP was greater than 750.Keywords
This publication has 14 references indexed in Scilit:
- Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitroAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirusAntimicrobial Agents and Chemotherapy, 1989
- Inhibition of duck hepatitis B virus replication by purine 2′,3′-dideoxynucleosidesBiochemical and Biophysical Research Communications, 1988
- Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenineBiochemical and Biophysical Research Communications, 1988
- Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitroAntimicrobial Agents and Chemotherapy, 1988
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Novel acyclic adenosine analogs inhibit Epstein-Barr virus replicationAntimicrobial Agents and Chemotherapy, 1987
- Antiviral activity of 2′,3′-dideoxycytidin-2′-ene (2′,3′-dideoxy-2′,3′-didehydrocytidine) against human immunodeficiency virus in vitroBiochemical Pharmacology, 1987
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986